Antiphospholipid antibody positivity and a history of methylprednisolone pulses were predictive of fetal loss among women with #systemiclupuserythematosus. #lupus https://www.rheumatologyadvisor.com/news/anti-ssa-ro-antibodies-not-linked-to-apos-in-sle/

Between 2022 and 2026, only 10.4% of stand-alone plans and 37.6% of #Medicare Advantage Part D plans covered DMARDs across all mechanisms of action. #rheumatology #healthequity https://www.rheumatologyadvisor.com/news/medicare-part-d-coverage-of-dmards-declines-across-plans/

Treatment with biologic and targeted synthetic DMARDs was associated with stabilized lung function among patients with #rheumatoidarthritis-associated #interstitiallungdisease. https://www.rheumatologyadvisor.com/news/dmards-preserve-lung-function-in-ra-ild/

Across 6 studies included in the systematic review and meta-analysis, the pooled prevalence of #interstitiallungdisease in #psoriaticarthritis was 3%. https://www.rheumatologyadvisor.com/news/ild-may-be-underrecognized-in-psa/

39% of caregivers of children with #rheumaticdisease reported at least 1 unmet social need, including food insecurity and financial strain. #healthequity https://www.rheumatologyadvisor.com/news/unmet-social-needs-linked-to-disparities-in-pediatric-rheumatic-disease/

Rates of antiphospholipid antibody positivity increased from 50.00% to 77.50% following SARS-CoV-2 (#COVID19) infection in pregnant patients with #antiphospholipidsyndrome. https://www.rheumatologyadvisor.com/news/sars-cov-2-infection-raises-apl-positivity-in-aps-pregnancies/

Higher visceral adipose tissue levels were consistently associated with higher #bonemineraldensity at the lumbar spine, femoral neck, and total body. #bonehealth https://www.rheumatologyadvisor.com/news/obesity-and-visceral-fat-linked-to-lower-osteoporosis-risk/

The FDA recently approved Sotyktu (deucravacitinib) for the treatment of active #psoriaticarthritis among adults. Test your knowledge on this new treatment with our latest quiz: https://www.rheumatologyadvisor.com/home/topics/psoriatic-arthritis/sotyktu-for-psoriatic-arthritis-quiz/

Declines in forced vital capacity over a 1-year period were linked to increased risks for 10-year mortality in patients with #idiopathicinflammatorymyopathy- associated #InterstitialLungDisease. https://www.rheumatologyadvisor.com/news/one-year-lung-function-decline-predicts-mortality-in-iim-ild/

Presumed sudden cardiac death occurred among 1.9% of the #systemicsclerosis study cohort. https://www.rheumatologyadvisor.com/news/incidence-of-scd-elevated-in-ssc/

Respondents reported multiple barriers to providing routine cognitive screening and neuropsychological evaluation in childhood-onset SLE (#lupus); only 28% felt able to adequately address cognitive concerns. https://www.rheumatologyadvisor.com/news/barriers-to-cognitive-screening-in-childhood-sle/

The European Alliance of Associations for Rheumatology recently released updated recommendations for physical activity in #inflammatoryarthritis and #osteoarthritis. Read our summary here: https://www.rheumatologyadvisor.com/news/2025-eular-update-to-physical-activity-recommendations-in-ia-and-oa/

In the year preceding diagnosis, children with #juvenileidiopathicarthritis had 134,650 total health care encounters, driven primarily by outpatient care. https://www.rheumatologyadvisor.com/news/health-care-use-rises-before-jia-diagnosis/

Incidence rate ratios demonstrated that #fracturerisk became significantly elevated in the year immediately prior to cancer diagnosis and persisted long term. #bonehealth https://www.rheumatologyadvisor.com/news/fracture-risk-increased-before-and-after-cancer-diagnosis/

A subset of patients with AAV-related diffuse alveolar hemorrhage also develop venous thromboembolic events, often requiring ICU care. #vasculitis https://www.rheumatologyadvisor.com/news/concurrent-dah-and-vte-in-aav-linked-to-high-morbidity-and-risk/

Among patients with #systemiclupuserythematosus (#lupus), each additional year of age was associated with a 2% reduction in the likelihood of medication nonadherence. https://www.rheumatologyadvisor.com/news/medication-nonadherence-decreases-with-age-in-sle/

In patients with #ankylosingspondylitis, exposure to TNF inhibitors was associated with a lower risk for vertebral fractures compared with bDMARD-naïve patients. #fracturerisk #bonehealth https://www.rheumatologyadvisor.com/news/biologic-exposure-linked-to-lower-osteoporosis-risk-in-as/

Do weight loss medications like #GLP1s have the potential to modify disease activity, boost treatment response, and improve quality of life in patients with #rheumaticdisease? Learn more: https://www.rheumatologyadvisor.com/features/weight-loss-medications-in-rheumatic-disease/